What do early stage companies really need to focus on? Patent attorney David Dykeman says, first and foremost, that it’s intellectual property protection. Dykeman –who co-chairs Greenberg Traurig’s global Life Sciences & Medical Technology Group – will speak at DeviceTalks Boston on October 2. We asked him to give us some ideas on the important issues surrounding […]